Bone mineral density and fractures in Turner syndrome

American Journal of Medicine

Volumn 115, Issue 4, 2003, Pages 259-264

  Bakalov, Vladimir K ^a   Chen, Michael L ^a   Baron, Jeffrey ^a   Hanton, Lori B ^a   Reynolds, James C ^b   Stratakis, Constantine A ^a   Axelrod, Lauren E ^a   Bondy, Carolyn A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FRACTURE; HUMAN; LUMBAR SPINE; OSTEOPOROSIS; PRIORITY JOURNAL; SCORING SYSTEM; TURNER SYNDROME;

EID: 0043234745     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00364-4     Document Type: Article

References (28)

1. Bercu B.B., Kramer S.S., Bode H.H. A useful radiologic sign for the diagnosis of Turner's syndrome. Pediatrics. 58:1976;737-739.
2. Rubin K. Turner syndrome and osteoporosis mechanisms and prognosis . Pediatrics. 102:1998;481-485.
3. Rao E., Weiss B., Fukami M., et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short-stature and Turner syndrome. Nat Genet. 16:1997;54-63.
4. Rao E., Blaschke R.J., Marchini A., Niesler B., Burnett M., Rappold G.A. The Leri-Weill and Turner syndrome homeobox gene SHOX encodes a cell-type specific transcriptional activator. Hum Mol Genet. 10:2001;3083-3091.
5. Clement-Jones M., Schiller S., Rao E., et al. The short-stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet. 9:2000;695-702.
6. Ogata T. SHOX pseudoautosomal homeobox containing gene for short-stature and dyschondrosteosis . Growth Horm IGF Res. 9:1999;53-58. (suppl B).
7. Ross J.L., Scott C. Jr, Marttila P., et al. Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab. 86:2001;5674-5680.
8. Naeraa R.W., Brixen K., Hansen R.M., et al. Skeletal size and bone mineral content in Turner's syndrome relation to karyotype, estrogen treatment, physical fitness, and bone turnover . Calcif Tissue Int. 49:1991;77-83.
9. Davies M.C., Gulekli B., Jacobs H.S. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clin Endocrinol (Oxf). 43:1995;741-746.
10. Sylven L., Hagenfeldt K., Ringertz H. Bone mineral density in middle-aged women with Turner's syndrome. Eur J Endocrinol. 132:1995;47-52.
11. Landin-Wilhelmsen K., Bryman I., Windh M., Wilhelmsen L. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf). 51:1999;497-502.
12. Benetti-Pinto C.L., Bedone A., Magna L.A., Marques-Neto J.F. Factors associated with the reduction of bone density in patients with gonadal dysgenesis. Fertil Steril. 77:2002;571-575.
13. Costa A.M., Lemos-Marini S.H., Baptista M.T., Morcillo A.M., Maciel-Guerra A.T., Guerra G. Jr. Bone mineralization in Turner syndrome a transverse study of the determinant factors in 58 patients . J Bone Miner Metab. 20:2002;294-297.
14. Ross J.L., Long L.M., Feuillan P., Cassorla F., Cutler G.B. Jr. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J Clin Endocrinol Metab. 73:1991;355-359.
15. Smith M.A., Wilson J., Price W.H. Bone demineralization in patients with Turner's syndrome. J Med Genet. 19:1982;100-103.
16. Preger L., Steinbach H.L., Moskowitz P., Scully A.L., Goldberg M.B. Roentgenographic abnormalities in phenotypic females with gonadal dysgenesis. A comparison of chromatin positive patients and chromatin negative patients. Am J Roentgenol Radium Ther Nucl Med. 104:1968;899-910.
17. Kelly T.L. Bone mineral reference database for American men and women. J Bone Miner Res. 5:1990;249-260.
18. Looker A.C., Wahner H.W., Dunn W.L., et al. Proximal femur bone mineral levels of US adults. Osteoporos Int. 5:1995;389-409.
19. Carter D.R., Bouxsein M.L., Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 7:1992;137-145.
20. Cummings S.R., Marcus R., Palermo L., Ensrud K.E., Genant H.K. Does estimating volumetric bone density of the femoral neck improve the prediction of hip fracture? A prospective study. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 9:1994;1429-1432.
21. Melton L.J. III, Khosla S., Achenbach S.J., O'Connor M.K., O'Fallon W.M., Riggs B.L. Effects of body size and skeletal site on the estimated prevalence of osteoporosis in women and men. Osteoporos Int. 11:2000;977-983.
22. Blake G.M. Measurement of bone density in the lumbar spine the lateral spine scan. Dunitz M. The Evaluation of Osteoporosis Dual Energy X-ray Absorptiometry. 2nd ed:1999;235-258 Dunitz, London.
23. Pors Nielsen S., Kolthoff N., Barenholdt O., et al. Diagnosis of osteoporosis by planar bone densitometry can body size be disregarded? Br J Radiol. 71:1998;934-943.
24. Gravholt C.H., Lauridsen A.L., Brixen K., Mosekilde L., Heickendorff L., Christiansen J.S. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome a cross-sectional study . J Clin Endocrinol Metab. 87:2002;2798-2808.
25. Gravholt C.H., Juul S., Naeraa R.W., Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol. 51:1998;147-158.
26. Garden A.S., Diver M.J., Fraser W.D. Undiagnosed morbidity in adult women with Turner's syndrome. Clin Endocrinol (Oxf). 45:1996;589-593.
27. Lanes R., Gunczler P., Esaa S., Martinis R., Villaroel O., Weisinger J.R. Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density. Fertil Steril. 72:1999;896-899.
28. Bechtold S., Rauch F., Noelle V., et al. Musculoskeletal analyses of the forearm in young women with Turner syndrome a study using peripheral quantitative computed tomography . J Clin Endocrinol Metab. 86:2001;5819-5823.